PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 114 filers reported holding PROVENTION BIO INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,075 | +141.6% | 86,095 | +5.9% | 0.00% | +200.0% |
| Q4 2022 | $859 | -99.7% | 81,291 | +8.6% | 0.00% | 0.0% |
| Q3 2022 | $337,000 | +26.2% | 74,864 | +12.2% | 0.00% | – |
| Q2 2022 | $267,000 | -48.6% | 66,748 | -5.9% | 0.00% | -100.0% |
| Q1 2022 | $519,000 | +19.0% | 70,938 | -8.7% | 0.00% | 0.0% |
| Q4 2021 | $436,000 | -11.9% | 77,666 | +0.5% | 0.00% | 0.0% |
| Q3 2021 | $495,000 | -22.8% | 77,315 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $641,000 | +11.7% | 76,077 | +39.0% | 0.00% | 0.0% |
| Q1 2021 | $574,000 | -39.2% | 54,739 | -1.8% | 0.00% | 0.0% |
| Q4 2020 | $944,000 | +44.8% | 55,754 | +9.8% | 0.00% | 0.0% |
| Q3 2020 | $652,000 | -18.6% | 50,787 | -10.5% | 0.00% | 0.0% |
| Q2 2020 | $801,000 | – | 56,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |